Skip to content Skip to menu

In partnership with key stakeholders, Medicines Australia drives the creation and development of an environment for the continued sustainable growth of the innovative research based prescription medicines industry

About Us

Papers, Reports & Submissions


Agreements, Indemnity & Compensation Guidelines

Clinical Trials

Awards, Speeches & Media Releases

Media & Events

Member company lounge

Member's Area

R&D Tax Incentive Review

Medicines Australia welcomes the release of the report commissioned by the Australian Government into the R&D Tax Incentive Programme. The report, authored by three of Australia’s most experienced business and scientific minds has outlined some interesting and worthwhile ideas to encourage more investment in Australian research and development which deserve further exploration by the Government…

View article· Wednesday, 28 September 2016

Ms Jane Halton AO PSM

Statement from Chairman Wes Cook On behalf of Medicines Australia and our members, I would like to acknowledge the work of Ms Jane Halton as Secretary of the Department of Finance and congratulate her on an exceptional career in public service. Ms Halton has spent many decades in public service  including her tenure as the…

View article· Friday, 16 September 2016

Streamlined approvals means faster access to medicines for patients

Medicines Australia welcomes the commitment of the Australian Government to improve the way medicines are assessed for use in Australia. The changes should provide patients with more rapid and early access to lifesaving, innovative medicines. The reforms are a direct response to the Medicines and Medical Devices Review which was tasked with improving and finding…

View article· Thursday, 15 September 2016

Code delivers new standard of transparency

Medicines Australia and its members are leading the way in providing greater transparency for consumers. The latest edition of the Code has delivered new standards of transparency for payments and transfers of value provided to healthcare professionals.  The reports published today provide clear information about payments for a doctor sharing their expertise and knowledge with…

View article· Wednesday, 31 August 2016

Appointment of new CEO

Medicines Australia, the peak body representing the Innovative Medicines Industry has today announced the appointment of Mr Milton Catelin as the new Chief Executive Officer of the organisation. Mr Catelin will commence the role from the week of 3 October 2016, after returning to Australia from the United Kingdom and will be based in Canberra….

View article· Wednesday, 24 August 2016

Medicines Australia supports world hepatitis day 2016

On the occasion of World Hepatitis Day, Medicines Australia calls for greater awareness about hepatitis and the ongoing need for disease prevention, testing and treatment. The day is particularly significant in Australia as it marks the year innovative therapies were introduced to the Pharmaceutical Benefits Scheme (PBS), achieving major advances in treatment for Hepatitis C,…

View article· Thursday, 28 July 2016

Shorten Shadow Ministry

Medicines Australia would like to congratulate the Hon. Bill Shorten as leader of the Opposition for the appointment of his Shadow Ministry following the Federal Election. The decision to re-appoint the Hon. Catherine King MP as the Shadow Minister for Health is a welcome decision and Medicines Australia congratulates Ms King for continuing in this…

View article· Sunday, 24 July 2016

Turnbull Government Ministry

Medicines Australia would like to acknowledge the appointment of the Turnbull Government Ministry following the Federal Election. With the recent confirmation that Prime Minister Turnbull will lead a majority government and today’s appointment of the Ministry, Medicines Australia looks forward to the resumption of Parliamentary business and policy development which is in the interests of…

View article· Monday, 18 July 2016

AusBiotech CEO

Medicines Australia would like to acknowledge the great contribution made by Dr Anna Lavelle to Australia’s biotechnology industry as she steps down from being the CEO of AusBiotech. Throughout her eleven years at the helm, Dr Lavelle has been a tremendous advocate for her members and the broader life science sector. Medicines Australia has had…

View article· Friday, 15 July 2016

World No Tobacco Day

World No Tobacco Day aims to draw attention to the harmful health effects of smoking. Every year, smoking kills around 15,000 Australians according to the Australian Institute of Health and Welfare. Australia already has some of the toughest smoking regulations in the world, and was the first country in the world to pioneer plain tobacco…

View article· Tuesday, 31 May 2016

Sign up for updates

Sign up for email updates to keep on top of Medicines Australia developments.


Streamlined approvals means faster access to medicines for patients

Congratulations Anna-Maria Arabia, the new CEO @Science_Academy Australia's talent in medical science helps develop new medicines + vaccines

Ten years today since first cervical cancer vaccine was administered. The HPV vaccine was developed in Aust. Local science, global vaccine.

1yr ago MA + @CHFofAustralia launched #workingtogetherguide a tool for healthy pharma/consumer relationships

MA members support all efforts to increase commercialisation of Aust medical science. Innovation improves lives.

Medicines Australia supports world hepatitis day 2016

Congrats @GregHuntMP on appointment as Minister for Industry, Innovation & Science. Crucial to Aust. future jobs, economy and health!

Congratulations Health Minister @sussanley. MA looks 4wd to working together on faster medicines access and clinical trial reform.

Attn. Aust healthcare workers: check @sanofipasteur Vaxigrants 4 x $25k grants to tackle immunisation uptake, visit

Congratulations @CSL - an example of the potential for biomedical science and advanced manufacturing in Australia.